Article: Firms can give FDA validation protocol to avoid 3-lot hassles. (Process validation).

NEWARK -- Manufacturers should ask FDA inspectors during a pre-approval audit to examine drug validation protocols in order to obviate any changes before three-lot validation is performed.

That's the advice of Nancy Rolli, a New Jersey district investigator, who handles many drug GMP and preapproval audits.

She told NAPM's mid-year meeting May 16 that firms should not be gun-shy about asking the FDA inspector to examine the protocol--if one is available--"because it's a lot easier to have them review it before you've done any work."

Rolli said this protocol should include not only a flow chart of the process but be specific in describing ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!